NeurologyVitamin B3 supplement fails to slow Parkinson's in a large trial
In the NOPARK trial of 410 people with early Parkinson's, a year of nicotinamide riboside left symptoms slightly worse than placebo, despite raising NAD levels in the blood.
8 October 2026